Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 66 results

A Plain Language Summary of Quality of Life with Sacituzumab Govitecan Treatment in the TROPiCS-02 Study in Participants with Breast Cancer (HR-Positive/HER2-Negative)

research A Plain Language Summary of Quality of Life with Sacituzumab Govitecan Treatment in the TROPiCS-02 Study in Participants with Breast Cancer (HR-Positive/HER2-Negative)

March 2025 in “Future Oncology”

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

research Bioidentical Hormone Replacement Therapy at a Hormone Clinic Causing Significant Virilization in a Post-Menopausal Woman

May 2021 in “Journal of the Endocrine Society”

A woman developed male characteristics after using unregulated hormone therapy.

research Frontal Fibrosing Alopecia: A Case Report of a 66-Year-Old Caucasian Woman

July 2015 in “Journal of the Dermatology Nurses’ Association”

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

research Epidermal Growth Factor, Innovation and Safety

10 citations , October 2015 in “Medicina Clínica (english Edition)”

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

research Cell/Tissue Microenvironment Engineering and Monitoring in Tissue Engineering, Regenerative Medicine, and In Vitro Tissue Models

4 citations , January 2014 in “BioMed Research International”

Engineering the cell microenvironment is key for advancing tissue engineering and regenerative medicine.

View more "bioinvent" in research →

Community Join

5 / 8 results

community HMI-115: What We Know So Far. HMI-115 (also known as BAY1158061) is a new pharmaceutical drug developed by a biopharmaceutical company called Bioinvent and licensed by Bayer

in Research/Science 51 upvotes 1 year ago

HMI-115 is a new drug developed by Bioinvent and licensed by Bayer, with mixed opinions on its potential effectiveness. Some users are skeptical and prefer proven treatments like Minoxidil, finasteride, and RU58841.

community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

in Research/Science 121 upvotes 1 year ago

The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

community Regrowth after 9 months of DHT blockers, and 6 months of HRT

in Transgender 12 upvotes 5 days ago

A 20-year-old saw significant hair regrowth after 9 months of using DHT blockers (finasteride and dutasteride) and 6 months of hormone replacement therapy (HRT) with estradiol. The regrowth is attributed to low testosterone and high estradiol levels, without using Minoxidil.

community How finasteride lowers brain's happiness steroid allopregnanolone and causes depression: systemic dihydroprogesterone crosses blood brain barrier, you don't even need finasteride and brain 5ar for that

in Finasteride/Dutasteride 286 upvotes 5 months ago

Finasteride may lower allopregnanolone levels, potentially affecting mood, but many users report improved mental health due to reduced hair loss. Experiences with finasteride and dutasteride vary, with some experiencing side effects and others finding them beneficial for hair retention and overall happiness.

community Female diffuse hair loss on spiro with irregular periods (photos) + genetic hair loss

in Female 16 upvotes 1 year ago

A 34-year-old woman is experiencing diffuse hair loss and irregular periods, possibly due to long-term spironolactone use. She is considering minoxidil and finasteride for treatment and seeking medical advice for androgenic alopecia and hormonal imbalances.

View more "bioinvent" in community →